Appears On
Episode Appearances
Biotech Hangout · May 8, 2026
Episode 182 - May 8, 2026
“Second attempted public company exit; Candid acquired by UCB for $2 billion; previously led Raised Bio”
Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis